|
OCIAD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71818115290989E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.10450545878871E-11 |
| Normal-vs-Stage2 |
3.85780000000668E-05 |
| Normal-vs-Stage3 |
9.2148511043888E-14 |
| Normal-vs-Stage4 |
1.62470037423645E-12 |
| Stage1-vs-Stage2 |
2.206400E-01 |
| Stage1-vs-Stage3 |
8.224400E-03 |
| Stage1-vs-Stage4 |
8.10509999999987E-05 |
| Stage2-vs-Stage3 |
5.824300E-03 |
| Stage2-vs-Stage4 |
1.812810E-04 |
| Stage3-vs-Stage4 |
1.529750E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.66133814775094E-16 |
| Normal-vs-AfricanAmerican |
6.029200E-04 |
| Normal-vs-Asian |
6.84260004213399E-09 |
| Caucasian-vs-AfricanAmerican |
6.328600E-01 |
| Caucasian-vs-Asian |
2.479600E-01 |
| AfricanAmerican-vs-Asian |
8.682800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.37500011376801E-11 |
| Normal-vs-Female |
2.0700108294136E-12 |
| Male-vs-Female |
7.062600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.25706170104468E-12 |
| Normal-vs-Age(41-60Yrs) |
2.51476617307844E-12 |
| Normal-vs-Age(61-80Yrs) |
5.56010792962525E-12 |
| Normal-vs-Age(81-100Yrs) |
3.999700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.297000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.976800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.786200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.014600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.677600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.284200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.44150000000754E-05 |
| Classical-VS-Follicular |
3.633100E-04 |
| Classical-VS-Other |
8.747000E-01 |
| Classical-VS-Normal |
1.63247193540883E-12 |
| Tall-VS-Follicular |
4.31220004148969E-09 |
| Tall-VS-Other |
3.789900E-02 |
| Tall-VS-Normal |
3.33066907387547E-16 |
| Follicular-VS-Other |
3.103000E-01 |
| Follicular-VS-Normal |
6.049200E-04 |
| Other-VS-Normal |
3.059400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.76030359364677E-11 |
| Normal-vs-N1 |
7.43849426498855E-15 |
| N0-vs-N1 |
1.416980E-03 |
|
|
